medigraphic.com

2015, Number 3

<< Back Next >>

Rev Elec Psic Izt 2015; 18 (3)

The Chronic Fatigue Syndrome and the benzodiazepines

Cedillo-Ildefonso B, Miralrio MC, Coffin CN

Language: Spanish
References: 30
Page: 962-976
PDF size: 420.25 Kb.


ABSTRACT

The Chronic Fatigue Syndrome (CFS) is a condition that affects life style of persons who present it. It is no quite possible to speak about an sole cause that triggers this Syndrome, since a multiplicity of researches have stated that several factors are immersed, such as generalized anxiety and depression. One of the symptoms in this anxiety frame is to develop an extreme ad quick fatigue, as long as sleep disorders, as well as concentration and memory retaining problems (typical of the CFS). These symptoms have been treated with different medications like benzodiazepines, which are more secure than barbiturics. Benzodiazepines are anxiolitics prescribed for the treatment of anxiety, sleep disorders, among other symptoms. The goal for this theoretical study was to show the relationship between different symptoms and the CFS, as long as the adequate pharmacological treatment based on benzodiazepines.


REFERENCES

  1. Asociación Catalana de afectados por el Síndrome de Fatiga Crónica (2003). Barcelona, España. http://www.sanytel.com/descargas/GuiaSFC_cast.pdf Alegre, recuperado el 16 de julio de 2009.

  2. Bertolína, J. M. y Bertolínb, V. (1993) Síndrome de fatiga crónica: investigaciones biológicas y psicopatológicas. Medicina Clínica, 101: 67-75.

  3. Brailowsky, S. (1995) Las sustancias de los sueños: Neurofarmacología. Cap. XVIII. Edit. SEP-Fondo de Cultura Económica, México.

  4. Carruthers, B.M., Jain A.K., De Meirleir, K.L., Peterson, D.L., Klimas, N.G., Lerner, A.M., Bested, A.C,, FlorHenry, P., Joshi, P., Powles, A.C.P., Sherkey, J.A., van de Sande, M.I. (2003). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. A Consensus Document.Journal of Chronic Fatigue Syndrome 11(1):7115.

  5. Chauchard, P. (1971). La Fatiga. Oikos- Tau Ediciones. Barcelona

  6. Fernandez-Solá, J. (2008). Identification of differential genetic profiles in severe forms of fibromyalgia and chronic fatigue syndrome/myalgic encephalomyelitis: a population-based genetic association study. Journal of Clinical Research 2008; 11: 1–24.

  7. Fernández Solá, A., Cuscó Segarra, A. y García Fructuoso, F. J. (2009). Afectación cognitiva en enfermos con fibromialgia, síndrome de fatiga crónica y fatiga crónica asociada a depresión. Aceptado para publicación en el XXXV Congreso Nacional de la Sociedad Española de Reumatología, Murcia, 20-22 mayo de 2009.

  8. Friedberg, F. y Jason, L. A. (1998). Understanding Chronic Fatigue Syndrome. American Psychological Association. Washington, DC, USA.

  9. García Blanco, S., Poca Dias, V., C Santos Pereira, Torrente Segarra, V. A Fernández Solá, A., Cuscó Segarra, A., García Fructuoso, F. J. (2009). Afectación cognitiva en enfermos con fibromialgia, síndrome de fatiga crónica y fatiga crónica asociada a depresión. Aceptado para publicación en el XXXV Congreso Nacional de la Sociedad Española de Reumatología, Murcia, 20-22 mayo de 2009.

  10. Garcia-Fructuoso, F. J., Lao-Villadoniga, J. I., Santos, C., Poca-Dias, V. y Fernández-Solá, J. (2008). Identification of differential genetic profi les in severe forms of fi bromyalgia and chronic fatigue syndrome/myalgic encephalomyelitis: a population-based genetic association study. Journal of Clinical Research 2008; 11: 1–24.

  11. Griebel, G., Perrault G., Simiand J., Cohen C., Granger P., Depoortere H., Francon D., Avenet P., Schoemaker H., Evanno Y., Sevrin M., George P. y Scatton B. (2003). SL651498, a GABA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Reviews. 9: 3-20.

  12. Heerlein, A. (2002). Tratamientos farmacológicos antidepresivos, Revista chilena de neuro-psiquiatría; 40 (1): 21-45.

  13. Hobbs, W. R., Rall, T. W. y Verdoom, T. A. (1998). Hipnóticos y sedantes: Etanol. Farmacología Terapéutica. México, Editorial Manual Moderno.

  14. Holmes, G.P., Kaplan, J.E., Gantz, N.M., Komaroff, A.L., Schonberger, L,B,, Straus, S.E. (1988). Chronic Fatigue Syndrome: a working case definition. Ann of Intern Med 1988; 108:387-389.

  15. Iversen, L. (2004). GABA pharmacology-what prospects for the future? Biochemical Pharmacology. 68:1537-1540

  16. Jason, L.A., Richman, J., Rademaker, A., Jordan, K., Plioplys, A., Taylor, R., Mc Cready, W., Cheng-Fang, H. y Plioplys, S. (1999). A community-based study of Chronic Fatigue Syndrome. American Medical Association.www.archinternmed.com, June 16, 2006.

  17. Jason, L., Fennell, P. y Taylor, R. (2003). Handbook of Chronic Fatigue Syndrome. John Wiley y Sons, Inc. N.J., USA

  18. Klein, R. L. y Harris, A. (1996). Regulation of GABAa receptor structure and function by chronic drug treatments in vivo and with stably transfected cells. Journal Pharmacology. 70: 1-15.

  19. Le, D.A., Mihic, S. J. y Wu, H. P. (1992). Animals models of drug addiction. Neuromethods. The Humana Press Inc. 24.

  20. McNamara, R. K. y Shelton, R. W. (1997). Tolerance develops to the spatial learning deficit produced by diazepam in rats. Pharmacology, Biochemistry and Behavior, 56: 383-389.

  21. Moldofsky, H. (1989). Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes. J Rheumatol. 16 Supl 19: 150-153.

  22. Moldofsky, H. (1993). Fibromyalgia, sleep disorder and chronic fatigue syndrome. CIBA Foundation Symp 173:262-279.

  23. Nutt, D. J. y Malizia, A. L. (2001). New insights into the role of the GABAa_ benzodiazepine receptor in psychiatric disorder. The British Journal of Psychiatric. 179: 390-396.

  24. O’ Brien, C. P. (1996). Adicción y Abuso de Sustancias. En Goodman, L. y Gilman, G. L. (Eds.). Las Bases Farmacológicas de la Terapéutica (pp. 598-599): México: MacGraw-Hill.

  25. Organización Mundial de la Salud http://www.who.int/es/, recuperado el 22 de mayo de 2009.

  26. Sanger, D. J., Jol, D. y Perrault, G. (1995). Benzodiazepine (w) receptor partial agonists and the acquisition of conditioned fear in mice. Psychopharmacology. 121: 104-108.

  27. Schmitt, U., Luddens, H. y Hiemke, C. (2001). Behavioral analysis indicates benzodiazepine-tolerance mediated by the benzodiazepine binding-site at the GABAa-receptor. Progress. Neuro-Psychopharmacology and Biological Psychiatry. 25: 1145-1160.

  28. Sternbarch, L. H. (1980). Benzodiazepines Today and Tomorrow, R.G. Priest, U. Vianna-Filho, R. Amrein, R. M. Skreta (Eds.), MTP Press Ltd, England, 5.

  29. m(www.institutferran.org/fatiga_cronica, recuperado el 25 de junio de 2009.

  30. (www.ei-resource.org/sindrome-de-fatiga-cronica.asp), recuperado el 13 de agosto de 2009.




2020     |     www.medigraphic.com